Tivity Health, Inc. (TVTY) Reports In-Line Q2 EPS; Offers FY18 EPS/Revenue Outlook

Go back to Tivity Health, Inc. (TVTY) Reports In-Line Q2 EPS; Offers FY18 EPS/Revenue Outlook

Tivity Health (TVTY) PT Lowered to $44 at Oppenheimer

August 3, 2018 9:26 AM EDT

Oppenheimer lowered its price target on Tivity Health (NASDAQ: TVTY) to $44.00 (from $50.00) while maintaining a Outperform rating.

... More